Evidence map›Paper›PMID 38098009›Full record

SynthesisBMC women's health2023

Survival rate of cervical cancer in Asian countries: a systematic review and meta-analysis.

Mohebat Vali, Zahra Maleki, Hossein-Ali Nikbakht, Soheil Hassanipour, Aida Kouhi, Sina Nazemi, Maryam Hajizade-Valokolaee, MohammadReza Nayeb, Haleh Ghaem

Open access · goldAbstract readMeta-AnalysisSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in BMC women's health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Determinants of Female Cancer Screening Awareness in Alabama's Black Belt Region.Asian Pacific journal of cancer prevention : APJCP · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Quality of Life of Emirati Women with Cervical Cancer Using EORTC QLQ-30 and CX24: A First Look in the UAE.International journal of environmental research and public health · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Mohebat Vali *Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Zahra Maleki *Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Hossein-Ali NikbakhtSocial Determinants of Health Research Center, Health Research Institute, Department of Biostatistics & Epidemiology, School of Public Health, Babol University of Medical Sciences, Babol, Iran.ORCID 0000-0002-8556-431X
Soheil HassanipourGastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.
Aida KouhiDepartment of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.ORCID 0000-0001-5848-1116
Sina NazemiDepartment of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.ORCID 0000-0001-6737-3037
Maryam Hajizade-ValokolaeeDepartment of Health, Health Systems Research, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.ORCID 0000-0001-9463-7018
MohammadReza NayebStudent Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Haleh GhaemNon-Communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. ghaemh@sums.ac.ir.
Shiraz University of Medical Sciences · IRBabol University of Medical Sciences · IRUniversity of Southern California · USGuilan University of Medical Sciences · IR

Funding

Shiraz University of Medical Sciences grant No. 1399-12-5-22520
6 · The paper itself

Abstract

objectiveCancer is one of the main causes of death, and cervical cancer is the fourth most common cancer and the fourth leading cause of death from malignancy among women. Knowing the survival rate is used to evaluate the success of current treatments and care. This study was conducted to assess the survival rate of cervical cancer in Asia.

methodsThis systematic survey was conducted on four international databases, including Medline/PubMed, ProQuest, Scopus, and Web of Knowledge, and includes manuscripts that were published until the end of August 2021. Selected keywords were searched for international databases including cervical neoplasms [mesh], survival analysis or survival or survival rate, Asian countries (name of countries). The Newcastle-Ottawa Qualitative Evaluation Form was used for cohort studies to evaluate the quality of the articles. The analysis process was performed to evaluate the heterogeneity of the studies using the Cochran test and I

resultsA total of 1956 articles were selected and reviewed based on their title. The results showed that 110 articles met the inclusion criteria. According to the randomized model, the 1, 3, 5, and 10-year survival rates of cervical cancer were 76.62% (95% Confidence Interval (CI), 72.91_80.34), 68.77% (95% CI, 64.32_73.21), 62.34% (95% CI, 58.10_66.59), and 61.60% (95% CI, 52.31_70.89), respectively. Additionally, based on the results of meta-regression analysis, there was an association between the year of the study and the survival rate, elucidating that the survival rate of cervical cancer has increased over the years.

conclusionsResults can provide the basic information needed for effective policy making, and development of public health programs for prevention, diagnosis, and treatment of cervical cancer.

Indexed as

Uterine Cervical NeoplasmsAsiaFemaleHumansSurvival AnalysisSurvival RateAsian countriesCervical cancerMeta analysisSurvival rate

Identifiers

PMID38098009
PMCPMC10722657
OpenAlexW4389764706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.